Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Acylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103467334B reveals high-yield synthesis for N-(2-chloro)-propionyl-glutamine. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104520275A details a novel synthetic route for HIV integrase inhibitors offering improved safety and supply chain reliability for pharmaceutical manufacturing.
Patent CN108299272B details a high-yield AlCl3-catalyzed route for fluorinated ketones, offering cost reduction and reliable supply chain solutions for pharmaceutical intermediates.
Patent CN101891794B details a novel ursolic acid piperazine derivative with superior antitumor activity. Discover scalable synthesis routes and cost-effective manufacturing strategies.
Patent CN109574866A reveals a scalable synthesis route for local anesthetic intermediates. This method offers significant cost reduction and supply chain reliability for global buyers.
Novel one-pot LDA method for 2-acetylcyclohexanone offers high purity and yield. Enhances supply chain reliability and reduces manufacturing costs for pharmaceutical intermediates.
Novel 5-step synthetic route for Lumefantrine Impurity 3 from 2,7-dichlorofluorene. Provides high-purity reference standards for antimalarial drug quality control and regulatory compliance.
Novel patent CN120774805A route for irinotecan intermediates. Higher yield, simplified steps, reliable pharmaceutical intermediate supplier for global scale-up.
Novel route for chlorantraniliprole key intermediate avoids benzoxazinone formation. High yield, low cost, scalable process for agrochemical manufacturing.
Novel four-step route achieves 88% yield and >99% purity for pharmaceutical intermediates, reducing bromine waste significantly.
Patent CN101205207B reveals a streamlined synthesis for herbicide intermediates, offering significant cost reduction and environmental benefits for global supply chains.
Patent CN102260272B details high-purity Irinotecan synthesis. Eliminates pyridine, improves yield, ensures supply chain reliability for pharmaceutical manufacturers globally.
Patent CN116925093A details a refined irinotecan synthesis using 1-methylpyrrolidine. This method offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel route for Tivozanib via Friedel-Crafts and cyclization. High yield, low cost. Ideal for reliable tivozanib intermediate supplier partnerships.
Novel regioselective acylation method improves yield and purity for temsirolimus production, offering supply chain stability and cost efficiency for global buyers.
Patent CN117024496A reveals a one-pot method for Mupiravir intermediates. Achieves 99.9% purity with reduced solvent use and simplified downstream processing for supply chains.
Advanced 5-step synthesis of FTY720 intermediate via patent CN1814583A. Offers significant cost reduction and high purity for immunosuppressant manufacturing.
Patent CN114560894B reveals a novel two-step route to Molnupiravir using Lewis acid catalysis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Patent CN110204557B details a high-yield silanization method for cefamandole nafate derivatives, offering superior purity and scalable manufacturing for global supply chains.
Patent CN1865234A reveals mild Wittig route for cis-capsaicin. Offers cost reduction and scalable supply for flavor and pharma industries.